Takeda gets key U.S. regulatory approval to buy Shire
0DAVID GODSTIMEJuly 10, 2018
Japan's Takeda Pharmaceutical Co Ltd said on Tuesday it received a key U.S. regulatory approval for its $62 billion deal to buy London-listed Shire Plc.
from Business & Finance via Godstime David on Inoreader https://ift.tt/2uep7oX
via IFTTT
we need your feedback